Login
$VRTX
$543.99 +$5.39 (1.0%) Live

$VRTX SEC Filings

Filed On Filing
16 Nov 2026 Form 4: Wagner Charles F Jr, EVP, CO & FO

Sold 15,286 shares ($8.37M)

16 Nov 2026 144
16 Nov 2026 144
13 Nov 2026 SCHEDULE 13G/A
12 Nov 2026 144
10 Nov 2026 Form 4: Kewalramani Reshma, Director

Sold 11,866 shares ($6.31M)

06 Nov 2026 144
03 Nov 2026 10-Q
02 Nov 2026 8-K: Results of Operations and Financial Condition

— Achieved total revenue of $3.44 billion, a 12% increase compared to third quarter 2025 —

22 Oct 2026 Form 4: Brennan Daniel J., Director

Received 795 shares as a grant or award ($400K)

22 Oct 2026 Form 3: Brennan Daniel J., Director

No securities owned

20 Oct 2026 8-K: Departure/Election of Directors or Officers; Compensation

(d) On October 20, 2026, Daniel Brennan was appointed as a new member of the board of directors (the “Board”) of Vertex Pharmaceuticals Incorporated (the “Company”). In connection with the appointment of Mr. Brennan, the size of the Boar...

19 Oct 2026 Form 4: Sachs Bruce I, Director

Granted 92.694 Deferred Stock Units ($47.5K)

19 Oct 2026 Form 4: Garber Alan M, Director

Granted 29.272 Deferred Stock Units ($15K)

10 Sep 2026 Form 4: van Grunsven Jasper, EVP, CP and NPPO

Received 8,682 shares as a grant or award

10 Sep 2026 Form 3: van Grunsven Jasper, EVP, CP and NPPO

No securities owned

01 Sep 2026 Form 4: Ambrose Kristen, SVP & Chief Accounting Officer

Received 5,000 shares as a grant or award

01 Sep 2026 8-K: Departure/Election of Directors or Officers; Compensation

On August 27, 2026, Vertex Pharmaceuticals Incorporated (the “Company”) appointed Jonathan Poole as Executive Vice President and Chief Financial Officer of the Company, effective January 1, 2027 (the “Effective Date”). In connection with...

31 Aug 2026 Form 4: Sachs Bruce I, Director

Gave 6,000 shares as a gift

27 Aug 2026 144

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support